Top Back to top

Evaluation of Outcomes following Allogeneic HCT in Pediatric Patients with High-Risk AML

Study number:
 
Short title:
 
Study status:
 
Deadline for data collection:
 
Study design:
 
Primary objective:
The primary end points are: overall survival
Secondary end points are: progression-free survival, non-relapse mortality, incidence of relapse
Key inclusion criteria:
 
Country:
 
Principal investigator:
Akshay Sharma
Principal investigator email:
Akshay.Sharma@STJUDE.ORG
EBMT Study coordinator:
Arnaud Dalissier
Study coordinator email:
arnaud.dalissier@upmc.fr